TrialInvestigational new drugs2016

A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors.

B Milojkovic Kerklaan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.